Back to User profile » Dr Henrik Watz

Papers published by Dr Henrik Watz:


Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET

Alter P, Stoleriu C, Kahnert K, Henke MO, Bals R, Trudzinski FC, Watz H, Speicher T, Söhler S, Welte T, Rabe KF, Wouters EFM, Vogelmeier CF, Jörres RA

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2911-2923

Published Date: 6 December 2023

Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study

Adams EJ, van Doornewaard A, Ma Y, Ahmed N, Cheng MK, Watz H, Ichinose M, Wilkinson T, Bhutani M, Licskai CJ, Turner KME

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2127-2146

Published Date: 27 September 2023

Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study

Mahler DA, Watz H, Emerson-Stadler R, Ritz J, Gardev A, Shaikh A, Drummond MB

International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1729-1740

Published Date: 10 August 2023

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET

Alter P, Kahnert K, Trudzinski FC, Bals R, Watz H, Speicher T, Söhler S, Andreas S, Welte T, Rabe KF, Wouters EFM, Sassmann-Schweda A, Wirtz H, Ficker JH, Vogelmeier CF, Jörres RA

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1703-1713

Published Date: 29 July 2022

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET

Fischer C, Jörres RA, Alter P, Trudzinski FC, Yildirim, Bals R, Vogelmeier CF, Kauffmann-Guerrero D, Behr J, Watz H, Holle R, Kahnert K

Patient Preference and Adherence 2022, 16:1759-1770

Published Date: 26 July 2022

Qualitative Validation of COPD Evidenced Care Pathways in Japan, Canada, England, and Germany: Common Barriers to Optimal COPD Care

Meiwald A, Gara-Adams R, Rowlandson A, Ma Y, Watz H, Ichinose M, Scullion J, Wilkinson T, Bhutani M, Weston G, Adams EJ

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1507-1521

Published Date: 1 July 2022

Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD

Abdo M, Pedersen F, Trinkmann F, Herth FJF, Rabe KF, Kirsten AM, Watz H

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1403-1408

Published Date: 17 June 2022

Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study

Koopman M, Franssen FME, Gaffron S, Watz H, Troosters T, Garcia-Aymerich J, Paggiaro P, Molins E, Moya M, van Burk L, Maier D, Garcia Gil E, Wouters EFM, Vanfleteren LEGW, Spruit MA

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:517-533

Published Date: 8 March 2022

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET

Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3189-3199

Published Date: 24 November 2021

The Relevance of Small Airway Dysfunction in Asthma with Nocturnal Symptoms

Abdo M, Trinkmann F, Kirsten AM, Biller H, Pedersen F, Waschki B, Von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H

Journal of Asthma and Allergy 2021, 14:897-905

Published Date: 13 July 2021

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences

Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, Vogelmeier CF, Kahnert K

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:987-998

Published Date: 14 April 2021

Persistent Uncontrolled Asthma: Long-Term Impact on Physical Activity and Body Composition

Abdo M, Waschki B, Kirsten AM, Trinkmann F, Biller H, Herzmann C, von Mutius E, Kopp M, Hansen G, Rabe KF, Bahmer T, Watz H

Journal of Asthma and Allergy 2021, 14:229-240

Published Date: 12 March 2021

Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant

Pedersen F, Trinkmann F, Abdo M, Kirsten AM, Rabe KF, Watz H, Baraldo S, Saetta M, Hohlfeld JM, Holz O

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:487-493

Published Date: 1 March 2021

Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus

Ramakrishnan S, Janssens W, Burgel PR, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:321-332

Published Date: 16 February 2021

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort

Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2787-2798

Published Date: 5 November 2020

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort

Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K

Patient Preference and Adherence 2019, 13:1711-1721

Published Date: 10 October 2019

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort

Alter P, Mayerhofer BA, Kahnert K, Watz H, Waschki B, Andreas S, Biertz F, Bals R, Vogelmeier CF, Jörres RA

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2163-2172

Published Date: 20 September 2019

Rating sputum cell quality in clinical trials for asthma and COPD treatment

Pedersen F, Zissler UM, Watz H, Rabe KF, Hohlfeld JM, Holz O

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:195-198

Published Date: 8 January 2019

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort

Greulich T, Mager S, Lucke T, Koczulla AR, Bals R, Fähndrich S, Jörres RA, Alter P, Kirsten A, Vogelmeier CF, Watz H

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2999-3002

Published Date: 28 September 2018

Identification of novel target genes in human lung tissue involved in chronic obstructive pulmonary disease

Heinbockel L, Marwitz S, Schromm AB, Watz H, Kugler C, Ammerpohl O, Schnepf K, Rabe KF, Droemann D, Goldmann T

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2255-2259

Published Date: 26 July 2018

Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD

Watz H, Bagul N, Rabe KF, Rennard S, Alagappan VKT, Román J, Facius A, Calverley PMA

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:813-822

Published Date: 6 March 2018

ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

Watz H, Troosters T, Beeh KM, Garcia-Aymerich J, Paggiaro P, Molins E, Notari M, Zapata A, Jarreta D, Garcia Gil E

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2545-2558

Published Date: 24 August 2017

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:981-987

Published Date: 22 March 2017

Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease

Rodriguez-Roisin R, Tetzlaff K, Watz H, Wouters EF, Disse B, Finnigan H, Magnussen H, Calverley PM

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1973-1981

Published Date: 22 August 2016

COPD: the patient perspective

Jones PW, Watz H, Wouters EFM, Cazzola M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:13-20

Published Date: 19 February 2016

Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD

Holz O, Roepcke S, Watz H, Tegtbur U, Lahu G, Hohlfeld JM

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1393-1402

Published Date: 21 July 2015